287 related articles for article (PubMed ID: 26888781)
1. Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glands.
Hirvonen K; Bäck L; Haglund C; Leivo I; Jouhi L; Mäkitie AA; Hagström J
Tumour Biol; 2016 Aug; 37(8):10959-64. PubMed ID: 26888781
[TBL] [Abstract][Full Text] [Related]
2. Early stage minor salivary gland adenoid cystic carcinoma has favourable prognosis.
Hämetoja H; Hirvonen K; Hagström J; Leivo I; Saarilahti K; Apajalahti S; Haglund C; Mäkitie A; Bäck L
Virchows Arch; 2017 Dec; 471(6):785-792. PubMed ID: 28600602
[TBL] [Abstract][Full Text] [Related]
3. Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
Bazarsad S; Kim JY; Zhang X; Kim KY; Lee DY; Ryu MH; Kim J
Yonsei Med J; 2018 Aug; 59(6):717-726. PubMed ID: 29978608
[TBL] [Abstract][Full Text] [Related]
4. Adenoid cystic carcinoma of the salivary gland: a clinicopathological study of 49 cases and of metallothionein expression with regard to tumour behaviour.
Brazão-Silva MT; Cardoso SV; de Faria PR; Dias FL; Lima RA; Eisenberg AL; Nascimento MF; Loyola AM
Histopathology; 2013 Dec; 63(6):802-9. PubMed ID: 24102890
[TBL] [Abstract][Full Text] [Related]
5. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of p53 immunohistochemical expression in adenoid cystic carcinoma of the salivary glands: a meta-analysis.
Li Q; Huang P; Zheng C; Wang J; Ge M
Oncotarget; 2017 Apr; 8(17):29458-29473. PubMed ID: 28206977
[TBL] [Abstract][Full Text] [Related]
7. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.
Schwarz S; Müller M; Ettl T; Stockmann P; Zenk J; Agaimy A
Int J Clin Exp Pathol; 2011 Apr; 4(4):336-48. PubMed ID: 21577319
[TBL] [Abstract][Full Text] [Related]
8. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
Ouyang DQ; Liang LZ; Ke ZF; Zheng GS; Weng DS; Yang WF; Su YX; Liao GQ
Head Neck; 2017 Jun; 39(6):1145-1154. PubMed ID: 28230926
[TBL] [Abstract][Full Text] [Related]
9. Expression of BTBD7 in primary salivary adenoid cystic carcinoma and correlation with Slug and prognosis.
Yang L; Wang T; Zhang J; Liu Z; Wang X
Cancer Biomark; 2016 Jun; 17(2):179-85. PubMed ID: 27540976
[TBL] [Abstract][Full Text] [Related]
10. High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma.
Vékony H; Raaphorst FM; Otte AP; van Lohuizen M; Leemans CR; van der Waal I; Bloemena E
J Clin Pathol; 2008 Jun; 61(6):744-9. PubMed ID: 18326020
[TBL] [Abstract][Full Text] [Related]
11. Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.
Sun J; Luo Y; Tian Z; Gu L; Xia SC; Yu Y
BMC Cancer; 2012 Oct; 12():499. PubMed ID: 23110497
[TBL] [Abstract][Full Text] [Related]
12. Glycoconjugate expression in adenoid cystic carcinoma of the salivary glands: up-regulation of L1 predicts fatal prognosis.
Dahl A; Teegen J; Altevogt P; Löning T; Schumacher U
Histopathology; 2011 Aug; 59(2):299-307. PubMed ID: 21884209
[TBL] [Abstract][Full Text] [Related]
13. Expression of RUNX3 in salivary adenoid cystic carcinoma: implications for tumor progression and prognosis.
He JF; Ge MH; Zhu X; Chen C; Tan Z; Li YN; Gu ZY
Cancer Sci; 2008 Jul; 99(7):1334-40. PubMed ID: 18410404
[TBL] [Abstract][Full Text] [Related]
14. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland.
Bell D; Ferrarotto R; Fox MD; Roberts D; Hanna EY; Weber RS; El-Naggar AK
Cancer Biol Ther; 2015; 16(6):834-8. PubMed ID: 25923130
[TBL] [Abstract][Full Text] [Related]
15. High podoplanin and low E-cadherin levels correlate with better prognosis in adenoid cystic carcinoma.
van der Wal JE; Sgaramella N; Norberg Spaak L; Zborayova K; Nylander K
Clin Exp Dent Res; 2019 Aug; 5(4):350-355. PubMed ID: 31452946
[TBL] [Abstract][Full Text] [Related]
16. High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.
Xia R; Zhou R; Tian Z; Zhang C; Wang L; Hu Y; Han J; Li J
Arch Pathol Lab Med; 2013 Dec; 137(12):1761-9. PubMed ID: 24283856
[TBL] [Abstract][Full Text] [Related]
17. Antizyme inhibitor 2 (AZIN2) associates with better prognosis of head and neck minor salivary gland adenoid cystic carcinoma.
Hämetoja H; Andersson LC; Mäkitie A; Bäck L; Hagström J; Haglund C
APMIS; 2021 Aug; 129(8):503-511. PubMed ID: 34046926
[TBL] [Abstract][Full Text] [Related]
18. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12.
Guan H; Tan J; Zhang F; Gao L; Bai L; Qi D; Dong H; Zhu L; Li X; Liu T
Histopathology; 2015 May; 66(6):781-90. PubMed ID: 25098606
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-7, -8, -9, -15, and -25 in minor salivary gland adenoid cystic carcinoma.
Hämetoja H; Mäkitie A; Bäck L; Leivo I; Haglund C; Sorsa T; Hagström J
Pathol Res Pract; 2021 Jan; 217():153293. PubMed ID: 33278774
[TBL] [Abstract][Full Text] [Related]
20. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.
Bell D; Bell AH; Bondaruk J; Hanna EY; Weber RS
Cancer; 2016 May; 122(10):1513-22. PubMed ID: 26953815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
